NAD+ nasal spray and IV therapy both aim to raise NAD+ levels, but they work differently. This physician-reviewed comparison explains which method suits which goals.

NAD+ therapy has expanded well beyond the IV infusion rooms where it first became popular. Today, patients can access NAD+ through oral precursors, nasal sprays, subcutaneous injections, and intravenous infusions. The question is no longer just whether NAD+ works but which delivery method makes sense for your goals, lifestyle, and physiology.

NAD+ cannot simply be swallowed and absorbed intact. When taken orally, NAD+ is broken down in the gut before it can enter circulation. This is why oral NAD+ supplements typically use precursor molecules, primarily nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), that the body can convert to NAD+ after absorption.

The challenge with precursor supplementation is conversion efficiency, which varies by tissue, age, and individual metabolic status. Getting NAD+ into the brain specifically is even more challenging, because the blood-brain barrier limits the passage of many molecules. This is where delivery method becomes particularly relevant.

Nasal spray formulations typically contain NAD+ itself rather than precursors. The nasal mucosa is highly vascularized, allowing rapid absorption into the bloodstream. The olfactory pathway additionally provides a more direct route to the brain, bypassing the blood-brain barrier that would otherwise limit NAD+ central nervous system delivery.

This mechanism is similar to why intranasal insulin delivery has been studied for cognitive applications, and why intranasal delivery is used for several pharmaceutical compounds where rapid brain delivery is desired. Published pharmacokinetic data on intranasal NAD+ specifically is limited, but the theoretical basis for enhanced CNS delivery via the nasal route is mechanistically sound.

IV NAD+ delivers the coenzyme directly into the bloodstream at controlled doses, bypassing all absorption barriers. This produces a rapid and predictable rise in blood NAD+ levels. IV administration is the delivery method with the longest clinical use history and the most documented applications.

IV NAD+ is used in addiction medicine, where high-dose infusions have been studied for their role in reducing withdrawal symptoms and cravings. It is also used in longevity and functional medicine clinics for energy optimization, cognitive support, and recovery protocols.

The limitations of IV therapy are practical rather than mechanistic. Sessions require clinic visits, typically last two to four hours, cost significantly more than non-IV options, and involve the discomfort of intravenous access.

For systemic NAD+ repletion, IV therapy delivers the highest and most immediate blood level increase. For brain-targeted delivery, nasal spray has a mechanistic advantage because of olfactory pathway access to the central nervous system. For daily maintenance and convenience, nasal spray is the clear practical choice because it can be used at home without clinic visits.

The populations best suited to IV NAD+ include those with significant NAD+ depletion who need rapid repletion, those in addiction recovery using high-dose protocols, and those who want documented, rapid blood level changes. Nasal spray is better suited to ongoing daily use for cognitive maintenance and patients for whom clinic visits are impractical.

Many patients use IV NAD+ to establish a baseline and then maintain with nasal spray or subcutaneous injections. This layered approach is increasingly common in physician-supervised longevity medicine programs.

A 2018 study published in Nature Communications established that oral NR supplementation raises NAD+ in human blood and muscle tissue, validating the precursor approach. A 2021 study in Cell Reports showed that systemic NAD+ precursor supplementation improved mitochondrial function in skeletal muscle in older adults. Direct comparison studies between intranasal and IV NAD+ in humans are currently limited. Most of the evidence for intranasal delivery is extrapolated from pharmacological principles and experience with other intranasally delivered compounds.


Individual results may vary. All prescriptions require approval by a licensed medical provider. Compounded medications are not FDA-approved. EllieMD facilitates access to independent healthcare providers and pharmacies and does not provide medical care or dispense medications.